Journal article
Can colony-forming unit testing be used to extend the shelf life of BCG vaccines?
NL Messina, S Germano, R Bonnici, LY Lee, AJ Daley, A Bustamante, P Jelfs, N Curtis
Tuberculosis | CHURCHILL LIVINGSTONE | Published : 2018
Abstract
A recent shortage in supply of Bacille Calmette-Guérin (BCG), the live attenuated vaccine given to protect against tuberculosis (TB) caused major disruption to global vaccination programs. In this study, we assessed whether quantification of viable bacteria, could be used to inform the use of the BCG vaccine beyond its manufacturer-assigned expiration date. The viability of a single batch of BCG-Denmark was tested in three independent laboratories. There was high inter-vial and inter-laboratory variability in viability counts, however all three laboratories detected a decrease in BCG viability over time. Despite this, there was no difference in the rate of BCG scar formation in infants who w..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by funding from the Australian National Health and Medical Research Council (grant number 1051228).